WHEN you think about industries with big potential for growth in Malaysia, chances are you will not immediately think about the clinical research industry.
However, as reported in May, the industry has brought in RM1.38bil in cumulative gross national income since 2012 for the country, with over 2,450 clinical trials conducted. And we stand to benefit further from the significant economic value of the global clinical trial market, which stood at over US$80bil (RM368bil) last year, with a projected growth of 6.5% annually.
